Pulmonary Involvement in Henoch-Schönlein Purpura

Nadrous, Hassan F.; Yu, Aimee C.; Specks, Ulrich; Ryu, Jay H.
September 2004
Mayo Clinic Proceedings;Sep2004, Vol. 79 Issue 9, p1151
Academic Journal
The article discusses the pulmonary involvement in Henoch-Schönlein Purpura (HSP). Pulmonary involvement in HSP is rare and occurs primarily in adults. The most common manifestation is diffuse alveolar hemorrhage (DAH) and occasionally usual interstitial pneumonia or interstitial fibrosis. DAH is associated with high mortality. Aggressive supportive care, including immunosuppressive therapy and mechanical ventilation, when needed, appears to be beneficial in the treatment of patients who manifest DAH associated with HSP.


Related Articles

  • EFFECTS OF MATRINE ON JAK-STAT SIGNALING TRANSDUCTION PATHWAYS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Xiuqin Ma; Ruhua Chen; Xiufang Liu; Jin Xie; Keyun Si; Lirong Duan // African Journal of Traditional, Complementary & Alternative Medi;2013, Vol. 10 Issue 3, p442 

    aims to investigate the effects of matrine on the JAK-STAT signaling transduction pathways in bleomycin (BLM)-induced pulmonary fibrosis (PF) and to explore its action mechanism. A total of 72 male C57BL/6 mice were randomized into the control, model, and treatment groups. PF models were...

  • Epidemiology of idiopathic pulmonary fibrosis. Ley, Brett; Collard, Harold R. // Clinical Epidemiology;2013, Vol. 5, p483 

    Idiopathic pulmonary fibrosis is a chronic fibrotic lung disease of unknown cause that occurs in adults and has a poor prognosis. Its epidemiology has been difficult to study because of its rarity and evolution in diagnostic and coding practices. Though uncommon, it is likely underappreciated...

  • Mycophenolate mofetil in diffuse cutaneous systemic sclerosis–a retrospective analysis. S. I. Nihtyanova; G. M. Brough; C. M. Black; C. P. Denton // Rheumatology;Mar2007, Vol. 46 Issue 3, p442 

    Objectives. We have assessed indications, duration and tolerability of treatment with mycophenolate mofetil (MMF) in patients with diffuse cutaneous systemic sclerosis (dcSSc), and compared clinical outcome with a control cohort treated with other immunosuppressive drugs.Methods. The clinical...

  • Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system†. De Oliveira, Nilto C.; Osaki, Satoru; Maloney, James; Cornwell, Richard D.; Meyer, Keith C. // European Journal of Cardio-Thoracic Surgery;Mar2012, Vol. 41 Issue 3, p680 

    OBJECTIVES This study was undertaken to evaluate whether the adoption of the united network for organ sharing lung allocation score (LAS) was associated with significant changes in lung transplantation (LTX) outcomes for patients with interstitial lung disease (ILD) who underwent LTX at the...

  • Early lung injury contributes to lung fibrosis via AT1 receptor in rats. Fang-ping Chen; Li-kun Gong; Ling Zhang; Hui Wang; Xin-ming Qi; Xiong-fei Wu; Ying Xiao; Yan Cai; Lin-lin Liu; Xiang-hong Li; Jin Ren // Acta Pharmacologica Sinica;Feb2007, Vol. 28 Issue 2, p227 

    Aim: Angiotensin II is believed to play an important role in tissue repair and remodeling in lungs by the angiotensin type I (AT1) receptor via a number of potential mechanisms. However, the role of the AT1 receptor in early lung injury has not been characterized. Methods: Bleomycin-induced...

  • Developmental responses to lung injury: repair or fibrosis. Warburton, David // Fibrogenesis & Tissue Repair;2012, Vol. 5 Issue Suppl 1, p1 

    Lung development is a complex and finely balanced process. Yet the lung has a relatively limited repertoire of responses to injury, which, depending on severity of the injury and developmental stage and susceptibility of the lung, culminate in stopping development, followed by more or less...

  • Prior Bleomycin Exposure in a Patient with a Difficult Airway. Whalen, James E. // International Student Journal of Nurse Anesthesia;Summer2009, Vol. 8 Issue 2, p29 

    Bleomycin is a chemotherapeutic antibiotic effective in the treatment of squamous cell, testicular, and lymphomatous cancers. The most serious complication of bleomycin is pulmonary fibrosis and impaired lung function. Hyperoxia in patients previously exposed to bleomycin may cause severe...

  • Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas. Lewis, Debbie; Scullion, Jane // International Journal of Palliative Nursing;Jul2012, Vol. 18 Issue 7, p331 

    Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening interstitial lung disease of unknown aetiology and with limited proven treatment options. As it is predominately a disease of older age, agrowing elderly population will increase its incidence. IPF has a poor prognosis, with...

  • "Healthy Smoker" Effect May Alter Prognosis in IPF.  // Pulmonary Reviews;Feb2008, Vol. 13 Issue 2, p9 

    The article discusses research being done on the prognosis of smokers and former-smokers with idiopathic pulmonary fibrosis (IPF). It references a study by Athol U. Wells and colleagues, published in the January 15, 2008 issue of the "Journal of Respiratory and Critical Care Medicine." The study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics